XML 49 R38.htm IDEA: XBRL DOCUMENT v3.4.0.3
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2016
Segment Reporting [Abstract]  
Summary Of Segment Performance



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

For the Three Months Ended March 31,

 



 

 

CAG

 

Water

 

LPD

 

Other

 

Unallocated Amounts

 

Consolidated Total

 

2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

357,639 

 

$

23,552 

 

$

30,856 

 

$

5,503 

 

$

 -

 

$

417,550 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

$

61,378 

 

$

9,679 

 

$

4,570 

 

$

(837)

 

$

(997)

 

$

73,793 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(7,484)

 

Income before provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

66,309 

 

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,284 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

46,025 

 

Less: Net income attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to IDEXX  Laboratories, Inc. stockholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

46,019 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

324,531 

 

$

21,698 

 

$

31,270 

 

$

4,978 

 

$

 -

 

$

382,477 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

$

53,518 

 

$

9,361 

 

$

6,956 

 

$

(322)

 

$

3,290 

 

$

72,803 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,879)

 

Income before provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

66,924 

 

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,346 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

46,578 

 

Less: Net loss attributable to noncontrolling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(16)

 

Net income attributable to IDEXX  Laboratories, Inc. stockholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

46,594 

 

 





 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Summary Of Revenue By Product And Service Category



 

 

 

 

 

 



 

For the Three Months Ended



 

March 31,



 

 

2016 

 

 

2015 

CAG segment revenue:

 

 

 

 

 

 

CAG Diagnostics recurring revenue:

 

$

305,510 

 

$

278,766 

IDEXX VetLab® consumables

 

 

107,959 

 

 

98,392 

IDEXX VetLab service and accessories

 

 

13,757 

 

 

13,530 

Rapid assay products

 

 

43,086 

 

 

43,637 

Reference laboratory diagnostic and consulting services

 

 

140,708 

 

 

123,207 

CAG Diagnostics capital - instruments

 

 

22,974 

 

 

20,113 

Customer information management and diagnostic imaging systems

 

 

29,155 

 

 

25,652 

CAG segment revenue

 

 

357,639 

 

 

324,531 



 

 

 

 

 

 

Water segment revenue

 

 

23,552 

 

 

21,698 

LPD segment revenue

 

 

30,856 

 

 

31,270 

Other segment revenue

 

 

5,503 

 

 

4,978 

Total revenue

 

$

417,550 

 

$

382,477